Lipocine

Liver
Biotech

Lipocine talks up interim data from small NASH study

Shares in the nanocap biotech shot up more than 100% in premarket trading before falling away somewhat as people dug deeper into the data.
Nick Paul Taylor Jan 17, 2019 9:45am
fda

Aradigm crashes after FDA panel votes down antibiotic

Jan 12, 2018 6:29am
FDA

FDA panel shoots down Lipocine low-testosterone drug

Jan 11, 2018 8:30am